sodium gluconate
Approved
Aug 13, 1975
Sodium gluconate is a compound with formula NaC6H11O7. It is the sodium salt of gluconic acid. Its E number is E576. This white, water-soluble powder has a wide range of applications across industries. Originally derived from gluconic acid in the 19th century, Sodium Gluconate is known for its chelating properties and is utilized as a chelating agent in various processes. It finds applications in textile, metal surface treatment, cement, and more. Moreover, its non-toxic nature and biodegradability contribute to its use in environmentally conscious practices. — Wikipedia
Clinical trial activity
2 trials · 4 clinical orgs · 6 marketing orgs
Earliest trial started Feb 28, 2011 (NCT01270854)
Timeline
1970s
- Aug 13, 1975
ICU Medical Inc — Earliest FDA Approval
- Aug 13, 1975
ICU Medical Inc — NDA Secondary Org
- Aug 13, 1975
ICU Medical Inc — NDA Organization
- Feb 2, 1979
Baxalta — NDA Secondary Org
- Feb 2, 1979
Baxter — NDA Secondary Org
Indications
Approved for
Mechanism of action
- Unspecified targetCHELATING AGENT
chelating agent
Combination products
isolyte s ph
with potassium chloride, sodium acetate, sodium phosphate, sodium chloride, potassium phosphate, magnesium
normosol-r
with potassium chloride, sodium acetate, sodium chloride, magnesium
Also known as isolyte s, physiolyte, physiosol, physiosol ph, plasma-lyte a
normosol-r and dextrose
with potassium chloride, sodium acetate, sodium chloride, glucose monohydrate, magnesium
Also known as isolyte s in dextrose, isolyte s w/ dextrose, plasma-lyte 148 and dextrose
Approval history
- approvedAug 13, 1975
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaSodium gluconate ↗
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05253209 | Phase 3 | Jun 29, 2022 | Asklepion, Indiana University |
| NCT01270854 | N/A | Feb 28, 2011 | Bayer, University of California, Davis |
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Asklepion | For profit | 1 | 1 | 1 | 2022 |
| Bayer | For profit | 1 | 0 | 1 | 2011 |
| Indiana University | Academic/Hospital | 1 | 0 | 1 | 2022 |
| University of California, Davis | Academic/Hospital | 1 | 1 | 1 | 2011 |
Marketing (7)
| Organization | Org type | Relationship | Date |
|---|---|---|---|
| B. Braun | For profit | NDA2 | Aug 5, 1980 |
| Baxalta | For profit | NDA2 | Feb 2, 1979 |
| Baxter | For profit | NDA2 | Feb 2, 1979 |
| Fresenius | For profit | MKTG | Jun 8, 2022 |
| Hospira | For profit | NDA2 | Aug 25, 1980 |
| ICU Medical Inc | For profit | NDA2 | Aug 13, 1975 |
| ICU Medical Inc | For profit | NDA | Aug 13, 1975 |